SENS compared with ALGS: revenue, margins and what each company keeps, and the suppliers and customers both name

SENSSenseonics Holdings, Inc.

Mkt capRevenueRevenue

ALGSAligos Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SENSSenseonics Holdings, Inc.

ALGSAligos Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SENS1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.6%▲+36.31%×3.13

ALGS1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+16.24%—

= impliedSENS realized, solidALGS realized, hatchedOne scale, both sides: full bar = 37%× = |realized| ÷ impliedSource: market data

SENSSenseonics Holdings, Inc.

7.98▼−11.53%· post 8.11

Mkt cap$476.9MRevenue$14MQ2 FY26Revenue$35MFY25

ALGSAligos Therapeutics, Inc.

4.68▼−6.73%· post 4.67

ClosedNov 5 '26

Mkt cap$62.7MRevenue$28MQ2 FY26Revenue$2MFY25

Compare

ClosedNov 5 '26

SENSSenseonics Holdings, Inc.

ALGSAligos Therapeutics, Inc.

7.98▼−11.53%post 8.11

Price

4.68▼−6.73%post 4.67

$476.9M

Mkt cap

$62.7M

Q2 FY26$14M

Revenue

$28MQ2 FY26

FY25$35M

Revenue

$2MFY25

SENS7.98▼−11.53%vsALGS4.68▼−6.73%ClosedNov 5 '26